Three OMER insiders, including two directors and the VP of Finance, sold a total of ~$387K in open-market shares over a one-week window. The cluster is 100% sells, with Director Hanish also exercising and immediately selling stock. At a $1.4B market cap, the total value is ~0.03%, well below the 0.1% materiality threshold, making this a routine, non-informative cluster likely driven by tax planning and vesting schedules rather than a bearish signal. The cross-filing actuarial verdicts are all amplifiers, but they apply to context pairs (e.g., cluster + earnings) that are not present here, this is a standalone sell cluster with no material cross-filing context to escalate it. Score is capped at 3 due to trivial dollar value and non-predictive sell-cluster nature. Sentiment is neutral. Confidence is high because the data is clear and the proportionality check is unambiguous. Key facts: total sells $387K, 0.03% of market cap, 3 insiders, 100% sells, no C-suite CEO/CFO participation, exercise-and-sell pattern suggests routine option monetization. Actionable insight: no actionable signal, this is noise. Monitor for any material insider BUY cluster or a CEO/CFO open-market sell to indicate a real shift in sentiment. Risks: none from this filing. Related tickers: none. Time horizon: immediate. Drug names: none. Cross-filing narrative: no material cross-filings to escalate. Data: netDirection selling, totalValue 387000, insiderCount 3, cSuiteCount 1 (Borges is VP, not C-suite; counted as non-C-suite per strict definition), possibleCatalyst null. ImpactScore 3 is appropriate for a trivial, sub-0.1%-of-market-cap sell cluster with no predictive value. Sentiment neutral. Confidence high. All data fields from the filing: $387K total sells, 3 insiders, 1 VP-level (not C-suite).
OMER drugs
OMER drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Aug 31 $18.79entry
- T+1 · 3mo ago −0.21%α +0.47% · $18.75
- T+5 · 2mo ago +1.76%α +1.90% · $19.12
- T+20 · 7w ago +2.45%α +2.82% · $19.25
- T+54 · todayOpen
- T+60 · in 7d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three OMER insiders, including two directors and the VP of Finance, sold a total of ~$387K in open-market shares over a one-week window. The cluster is 100% sells, with Director Hanish also exercising and immediately selling stock. At a $1.4B market cap, the total value is ~0.03%, well below the 0.1% materiality threshold, making this a routine, non-informative cluster likely driven by tax planning and vesting schedules rather than a bearish signal. The cross-filing actuarial verdicts are all amplifiers, but they apply to context pairs (e.g., cluster + earnings) that are not present here, this is a standalone sell cluster with no material cross-filing context to escalate it. Score is capped at 3 due to trivial dollar value and non-predictive sell-cluster nature. Sentiment is neutral. Confidence is high because the data is clear and the proportionality check is unambiguous. Key facts: total sells $387K, 0.03% of market cap, 3 insiders, 100% sells, no C-suite CEO/CFO participation, exercise-and-sell pattern suggests routine option monetization. Actionable insight: no actionable signal, this is noise. Monitor for any material insider BUY cluster or a CEO/CFO open-market sell to indicate a real shift in sentiment. Risks: none from this filing. Related tickers: none. Time horizon: immediate. Drug names: none. Cross-filing narrative: no material cross-filings to escalate. Data: netDirection selling, totalValue 387000, insiderCount 3, cSuiteCount 1 (Borges is VP, not C-suite; counted as non-C-suite per strict definition), possibleCatalyst null. ImpactScore 3 is appropriate for a trivial, sub-0.1%-of-market-cap sell cluster with no predictive value. Sentiment neutral. Confidence high. All data fields from the filing: $387K total sells, 3 insiders, 1 VP-level (not C-suite).
Financial Impact
Not specified
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-OMER-1787983371778 |
Track record
12 reports on OMER
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +98.11% at T+60 after the Jul 20, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $16.92 Now $16.68 −1.42% settles Feb 4
- Oct 30, 202617d ago 8-K Neutral 3/10 Entry $17.83 Now $16.68 −6.45% settles Jan 29
- Sep 1, 202610w ago Insider Cluster Neutral 2/10 Entry $18.86 Now $16.68 −11.56% settles Nov 27
- Aug 28, 202611w ago Insider Cluster Neutral Not scored Viewing Entry $18.79 Now $16.68 −11.23% settles Nov 24
- Aug 25, 202611w ago Insider Cluster Neutral 3/10 Entry $18.22 Now $16.68 −8.45% settles Nov 19
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $19.32 Now $16.68 −13.66% settles Nov 17
- Jul 20, 202617w ago 8-K Bullish 5/10 Entry $9.53 to $18.88 Now $16.68 +75.03% ▲ +98.11% +94.14% vs SPY
- Jul 6, 202619w ago 8-K Neutral 4/10 Entry $10.34 to $19.25 Now $16.68 +61.32% ▲ +86.17% +84.45% vs SPY
- Jun 18, 202621w ago 8-K Bullish 5/10 Entry $10.28 to $17.46 Now $16.68 +62.26% ▲ +69.84% +67.95% vs SPY
- Jun 11, 202622w ago Institutional Cluster Neutral 4/10 Entry $10.18 to $18.95 Now $16.68 +63.85% ▲ +86.15% +81.75% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers